Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Teva Pharmaceutical Beats Estimates As Top Line Rises 12% Amid N. America Strength

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
189 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jul 27, 2010

Jerusalem-based drugmaker Teva Pharmaceutical (NASDAQ:TEVA) reported Q2 EPS of $1.08, topping consensus estimates of $1.04.

Revenues in the quarter rose 12% to $3.8 billion, inline with consensus estimates.

The company highlighted its outperformance in the North America region, where it unveiled nine new products during the second-quarter.

Category:

News & Politics

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more